CATX Perspective Therapeutics Inc slips 141 after reporting Q4 2025 EPS that misses analyst estimates by 403 DT Dynatrace Inc tops Q1 2026 EPS estimates shares rise on 188 percent year over year revenue growth What Aeva AEVA is doing that creates lasting advantage Q1 2026 EPS Tops Views How Autonomix AMIX stacks up against analyst expectations Flirts with Support 20260508 The bullish narrative around JDcom rests on several interconnected factors that merit close attention from investors VIAV Viavi Solutions tops Q1 2026 EPS estimates by 145 percent shares gain 559 percent in todays session Is EZCORP EZPW stock aligned with valuation metrics Q1 2026 EPS Beats Forecasts Consumer Credit Growth Surges in December Implications for Economic Activity G7 Unity Under Strain as Members Reportedly Consider Abandoning Joint Communique for 2026 Coastal Erosion Threatens UK Infrastructure The Slapton Line Collapse and Economic Implications Morgan Stanley Downgrades Aegon to Equal Weight Citing Valuation Concerns in European Insurance Sector Chinas YearLong Space Mission Signals Ambition for 2030 Moon Landing and Lunar Base Sebi Bars Seven Entities for Stock Manipulation via Social Media Freezes 20 Crore Gains LOVE Q1 2026 Earnings EPS Beats Estimates by 682 CTRI Q1 2026 Earnings EPS Surprises Positively Despite Loss Stock Declines SeaStar Medical Holding Corporation ICU Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Development Costs BioCardia Inc BCDA Q1 2026 Earnings Misses EPS Estimates Amid No Revenue NEU Q1 2026 Earnings Strong EPS Performance Amidst Operational Stability CMI Q1 2026 Earnings EPS Beats Estimates by 897 as Shares Rally CrossAmerica Partners CAPL Holds Steady With Modest Gain as Consolidation Continues Extreme Networks EXTR Surges 7 on Strong Volume Approaches Resistance at 2688 ENvue Medical Inc FEED Dips 83 as Shares Approach Key Support at 088 CO2 Energy Transition Corp Warrant NOEMW Surges Over 24 Key Levels to Watch Masonglory Limited MSGY Slides 149 Toward Key Support as Bearish Momentum Continues Jim Cramers Morning Meeting Buy Sell and One Stock with Potential 30 Upside CFBK Q1 2026 Earnings EPS Misses Estimates Stock Holds Steady Keros Therapeutics KROS Edges Higher Amid Consolidation Near Key Resistance